InnoCare Pharma Limited

INCPF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$6,222,626$8,224,596$8,697,927$5,928,716
Short-Term Investments$1,062,899$0$313,290$317,059
Receivables$371,164$276,378$127,825$45,273
Inventory$95,577$119,095$65,322$9,918
Other Curr. Assets$67,922$145,254$95,344$116,145
Total Curr. Assets$7,820,188$8,765,323$9,299,708$6,417,111
Property Plant & Equip (Net)$814,273$1,089,039$952,213$502,366
Goodwill$3,125$3,125$3,125$3,125
Intangibles$35,918$39,007$41,305$139,446
Long-Term Investments-$603,312$5,660-$301,578$9,039
Tax Assets$603,312-$5,660$0$275,493
Other NC Assets$733,990$22,635$326,385$50,951
Total NC Assets$1,587,306$1,153,806$1,021,450$980,420
Other Assets$0$0$0$0
Total Assets$9,407,494$9,919,129$10,321,158$7,397,531
Liabilities
Payables$128,363$134,905$118,597$84,602
Short-Term Debt$225,405$1,274,364$1,217,280$13,505
Tax Payable$31,113$15,253$32,580$37,360
Deferred Revenue$0$0$280,034$6,831
Other Curr. Liab.$676,123$669,472$426,937$187,004
Total Curr. Liab.$1,061,004$2,093,994$2,075,428$329,302
LT Debt$1,046,140$69,947$323,200$1,248,006
Deferred Rev, NC$251,281$268,906$278,203$123,611
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$303,134$305,577$278,203$37,693
Total NC Liab.$1,600,555$644,430$601,403$1,409,310
Other Liabilities$0$0$0$0
Cap. Leases$59,048$66,880$55,551$67,778
Total Liabilities$2,661,559$2,738,424$2,676,831$1,738,612
Equity
Pref Stock$0$0$0$0
Common Stock$23$23$23$19
Retained Earnings-$5,494,824-$5,054,191-$4,422,928-$3,536,335
AOCI$0$0$263,726-$230,851
Other Equity$12,220,102$12,202,017$11,756,280$9,371,726
Total Equity$6,725,301$7,147,849$7,597,101$5,604,559
Supplemental Information
Minority Interest$20,634$32,857$47,226$54,360
Total Liab. & Tot. Equity$9,407,494$9,919,129$10,321,158$7,397,531
Net Debt-$4,951,081-$6,880,285-$7,157,447-$4,667,205
InnoCare Pharma Limited (INCPF) Financial Statements & Key Stats | AlphaPilot